Press & Media

A new era of adolescent metabolic health.

Thryvwell is building a parent-first, clinician-guided virtual care experience for adolescents ages 12–17 and the families supporting them.

Pediatric care, by design

Thryvwell is focused on clinician-guided metabolic health care for adolescents ages 12–17 and their families.

Parent-first participation

A legal guardian participates throughout the pediatric care journey, from intake through ongoing clinical monitoring.

Information for reporting

Media teams can request current background information, approved brand materials, and leadership context through our contact team.

Media inquiries

For current background information, approved materials, or a conversation with the Thryvwell team, please contact us through the inquiry form.

Contact Thryvwell
Thryvwell Health

Parent-first pediatric metabolic health care for adolescents ages 12–17. We provide specialized clinical oversight, practical family support, and educational content to build lasting health habits.

Stay updated on Thryvwell Health

Enter your email for news and early access. No spam, ever.

¹ CDC NHANES 2017–2020 | ² AAP Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity, 2023. *Individual results may vary. Statistics reflect clinical trial outcomes (Weghuber et al., NEJM 2022) in adolescents ages 12–17 receiving semaglutide 2.4 mg plus lifestyle intervention over 68 weeks. Treatment requires a prescription and medical supervision. The information on this website is for educational purposes only and does not constitute medical advice. GLP-1 medications are prescription-only and are prescribed based on individual clinical eligibility.

© 2026 Thryvwell Health, LLC. All rights reserved. All content, images, and materials are proprietary.

HIPAA CompliantFDA-Approved Medications OnlyAligned with Medicaid Quality Metrics

See if your family qualifies

Get Started